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Abstract: Aim: To investigate the effects of
oral L-glutamine, insulin and laxative on the
severity of acute pancreatitis.
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Materials and Methods: Forty adult male
Sprague-Dawley rats were divided into 4
groups. Experimental pancreatitis was
induced by ligating the main biliopancreatic
duct. All groups were given standard rat
pellets and tap water. In addition Group II was
given 15 mg/kg/day of L-glutamine via a
catheter enterally, Group III was given a 3
ml/day fleet enema via a catheter enterally,
and Group IV was given 3 IU/kg/day of NPH
insulin via a catheter enterally. The rats were
sacrificed 96 hours after the induction of
pancreatitis. Blood samples for biochemical
analyses, and tissue samples from the lung
and pancreas for histopathological evaluation
were taken.
Findings: Significant increases in amylase
levels were observed after the procedure. Five
parameters in the L-glutamine group (BUN,
glucose, leukocyte, pO2 and SGOT), 5

Introduction
Acute pancreatitis is a serious clinical condition
triggered by several factors, among which alcohol and
bile stones are the most important, and it has a varying
course (1-3). No specific methods or drugs have yet been
defined for the treatment of acute pancreatitis. The aims
of the conventional methods may be summarized as
relieving the pain and preventing development of
complications, and, if they develop, treating them. Among
these options, ceasing enteral nutrition and nasogastric
tube decompression play an important role (3).
Until recently, it was believed that enteral feeding
would increase the severity of acute pancreatitis by
stimulating excretion of gastrointestinal fluids and
pancreas enzymes (3,4). However, some authors led by
Imrie argue that enteral nutrition in mild and moderate
acute pancreatitis cases will not increase the severity of
the disease, but rather may have positive effects (5-8).

parameters in the laxative group (Amylase,
BUN, glucose, LDH and SGOT), and 2
parameters in the insulin group (BUN and
SGOT) were better than those in the control
group. While necrosis was observed in 3 rats
in the control group, 3 in the insulin group
and in 1 in the laxative group in the
histopathological evaluation of pancreas
tissue, no rats in the L-glutamine group
exhibited necrosis. More severe pancreatitis
was observed in the control and insulin
groups (p<0.05).
Conclusion: L-glutamine, administered in
enteral solutions in subjects with acute
pancreatitis, will not increase the severity of
pancreatitis, but will aid in meeting the energy
demand of the subject. Laxative may also be
employed in the removal of fecal mass during
the early period of the disease.
Key Words: Acute Pancreatitis, L-glutamine,
Laxative, Insulin, Pancreatic Necrosis,
Prognosis

The occurrence of septic complications during the
course of the disease affects the prognosis adversely. It
has been demonstrated that the source of pancreatic
sepsis is intestinal bacteria, and that these bacteria reach
the pancreas via blood circulation and/or directly (9-11).
Bacterial translocation becomes easier in an ischemic and
stasis environment. The strength of mucosal barriers in
the intestine and the removal of stasis prevent bacterial
translocations (12,13).
In this experimentally induced acute pancreatitis
model, we investigated the effects of on the prognostic
parameters in the blood and on tissue damage of the
following: L-glutamine, which is known to have trophic
effects on intestinal mucosa; insulin, which is used orally
in the treatment of several autoimmune diseases; and
laxative, which has been proven to reduce intestinal
flora.
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Materials and Methods
This study was performed in Selcuk University
Experimental Medical Research Center, upon permission
of Selcuk University Ethics Committee and upon approval
of the Executive Board of the Research Center. The
Turkish Law of Animal Rights was taken into account in
this study.
Forty adult male Sprague-Dawley rats were included
in the study. Their weights were 230-270 g (mean: 248
± 14 g). The rats were divided equally into 4 groups. All
the rats were fed with standard rat pellets and tap water
until the eve of the experiment, and then they were
fasted. They were anesthetized with 5 mg/kg Ketamine
HCl. Hair on the abdominal wall was shaved off, and
Betadine solution was applied, after which the abdomen
was entered by a midline incision under sterile conditions.
The main biliopancreatic duct was isolated and ligated
with 3/0 silk from the point just before the duodenum.
Abdominal layers were closed by a continuous suture
using 3/0 silk. After being placed into their cages, the rats
were kept under controlled humidity and temperature
conditions.
The groups and their respective nutrition were as
follows:
Group I: Control group; standard rat pellets and tap
water were given
Group II: L-glutamine group; standard rat pellets and tap
water + 15 mg/kg/day L-glutamine (Lglutamine, GNC) via a catheter enterally.
Group III: Laxative group; standard rat pellets and tap
water + fleet enema (Sodium Phosphate, Fleet
Enema; C.B. Fleet Company, USA) via a
catheter enterally.
Group IV: Insulin group; standard rat pellets and tap
water + 3 IU/kg/day insulin (Humuline N; Lilly)
via a catheter enterally.
The rats were re-anesthetized with 5 mg/kg Ketamine
HCl at the postoperative 96th hour. A 7 cc blood sample
was taken by cardiac puncture. Of this, 1 cc was put into
a heparinized injector for the study of blood gases,
another 1 cc was placed into a tube containing EDTA for
hematological examinations, and 5 cc was preserved for
biochemical analyses. Tissue samples taken from the
pancreas and the lung were preserved in formaline
solution. Paraffin blocks were prepared from the tissue
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samples, and sectioned for microscopic assessment.
These sections were stained with Hematoxylin-Eosine.
Then they were examined under a light microscope, in
which the presence of interstitial edema, infiltration of
inflammatory cells, hemorrhagic areas and necrosis was
investigated. For each finding a score of 1 point was
given, and the severity of the pancreatitis was determined
by adding the obtained points. The overall scores were
between 0 and 4 (0: no pancreatitis, 1: mild pancreatitis,
2-3: moderate pancreatitis, and 4: severe pancreatitis).
Statistical analyses were performed according to the
Kruskal-Wallis test and the Mann-Whitney U test. The
significant values were checked by Tukey HSD test.
Values of p<0.05 were considered significant.

Findings
All the rats survived the experimental period. The
results of the biochemical, hematological and gasometric
determinations are summarized in Table 1.
Amylase levels were found to be higher than normal.
This implies that the model we applied produces
successful pancreatitis. Amylase levels in the laxative
group after the experiment found to be significantly
lower than those in the control group (p=0.02). There
were no significant differences among the other groups
(p>0.05). Leukocyte counts and levels of BE, Ca2+ and
hematocrit were similar in all the groups (p>0.05). Levels
of BUN and SGOT were found to be significantly higher in
the control group than in the other groups (p<0.05).
However, there was no difference among the other
groups (p>0.05). Glucose levels were significantly lower
in the glutamine and laxative groups than in the control
group (p<0.05), similar between the control and insulin
groups (p>0.05), and significantly lower in the laxative
group than in all the other groups (p<0.05). pO2 levels
were significantly higher in the glutamine group than in
all the other groups (p<0.05). LDH levels were found to
be lower in the laxative group than in the control group
(p<0.05).
Five parameters in the L-glutamine group (BUN,
glucose, leukocyte, pO2 and SGOT), 5 parameters in the
laxative group (amylase, BUN, glucose, LDH and SGOT),
and 2 parameters in the insulin group (BUN and SGOT)
were better than those in the control group. In the
glutamine group, 2 parameters (SGOT and pO2) were
better than in the insulin group, 1 parameter (pO2) was
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better than in the laxative group, and 1 parameter
(glucose) was worse than in the laxative group.
Severity of pancreatitis in the groups is given in Table
2 according to the histopathological evaluation of the
pancreas (Figure 1,2). In the control group, 1 rat had
mild pancreatitis, 6 rats had moderate pancreatitis and 3
rats had severe pancreatitis. These figures were 5 mild, 5
moderate and 0 severe in the glutamine group; 3 mild, 6
moderate and 1 severe in the laxative group; and 2 mild,
5 moderate and 3 severe in the insulin group. The
severity of the pancreatitis in the glutamine and laxative
groups was lower than in the control and insulin groups
(p<0.05). The insulin group and the control group were
found to be similar (p>0.05), as were the glutamine
group and the laxative group.
Significant increases were observed in the infiltration
of inflammatory cells and edema in lung tissue in the
control group and insulin group (Figure 3).

Discussion
The basal energy consumption of patients increases in
acute pancreatitis depending on the severity of the

Parameters
Amylase (IU/dl)
SGOT (IU/dl)
LDH (IU/dl)
Glucose (mg/dl)
BUN (mg/dl)
Ca2+ (mEq/L)
Htc. (%)
Leukocyte (mm3)
BE mmHg
pO2 mmHg

Score (s)

disease. In the event of this energy requirement not being
met from exogenous sources, the patient uses
endogenous energy reserves, as a result of which the
body’s structural elements are rapidly used up and the
patient loses weight. During this period, widespread
inflammation and necrosis develops in the pancreas and in
peripancreatic and retroperitoneal regions. In patients
under these conditions, organic functions deteriorate
progressively and the mortality rate increases (13-16).
It is emphasized that supportive nutritional treatment
in the early period of the disease should be started in
patients with heavy pancreatitis in order to end the
catabolic phase, to prevent deterioration of organic
functions and to alleviate disfunctions of affected
organs(15,17,18). Several clinical studies have shown
that total parenteral nutrition (TPN) prevents nitrogen
losses in acute pancreatitis (17,19). Currently, TPN is still
accepted as a standard treatment method in patients who
require nutritional treatment (7,17,19-21). However,
due to its high cost and significant complications, it is
proposed that enteral nutrition may be an alternative to
TPN (6-8,20). Kalferentzos et al. (7), in their clinical
study, fed a group of patients with acute pancreatitis via

Group I

Group II

Group III

Group IV

180±32
736±120
1669±411
172±8.7
73±9
7.4±0.9
27.3±2.8
14±1.5
-1.46±1.36
64±6.2

158±33
343±230
1271±419
151.4±22.5
55±14
8±1
29.6±2.5
12.5±1.7
-1.5±1.4
72.2±5.5

125±24
526±77
1084±202
115.1±12.5
57±12
7.9±0.7
28.6±2.4
12.5±2.1
-1.1±1.2
64.9±4.7

148±33
538±166
1329±432
165.5±23
56±7
7.9±0.3
29.4±2
12.5±1.7
-1.1±1.6
64.9±6.1

Group I (n)

Group II (n)

Group III (n)

Group IV (n)

O
1
2
3
4

1
2
4
3

5
4
1
0

3
4
2
1

2
2
3
3

Total1

29

16

21

27

Table 1.

Biochemical, Hematological and
Gasometric Parameters.

Table 2.

Severity of pancreatitis in the
groups.

1
Total score was obtained by multiplying the number of the subjects (n) in a group by the score
(s) corresponding to it (Total = s x n).
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Figure 1.

Microscopic view of a rat’s pancreas in the
control group. Necrosis can be seen
(Hematoxylin-Eosin, x200).

Figure 2.

Microscopic view of a rat’s pancreas in the
L-glutamine group. Normal pancreatic tissue
can be seen. (Hematoxylin-Eosin, x200)

Figure 3.

Lung section of a rat in the insulin group.
Edema and infiltration of inflammatory cells
can be seen (Hematoxylin-Eosin, x200).
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a nasoduodenal tube while they applied TPN to another
group of patients. They found that the rates of septic and
total complications were significantly lower in the group
fed enterally.
Ceasing oral feeding is an important part of the
conventional treatment of patients with acute
pancreatitis, because it is believed that oral feeding leads
to the pancreatic enzymatic activation and increases the
severity of the disease by stimulating gastrointestinal
secretions and hormone release (1-3,22,23). Sahin et al.
(6), in their experimental study, reported that, in rats fed
enterally, some biochemical parameters were affected
adversely but pancreatic tissue was in better condition in
the histopathological examination.
We observed that biochemical and histopathological
parameters in the L-glutamine and laxative groups were
better than those in the control and insulin groups. It was
shown in various studies that L-glutamine was the most
important energy source for enterocytes, and that it
increased protein amounts in the plasma and protein
synthesis in muscular tissue (24-27). Kartal et al. (28)
reported that L-glutamine prevented atrophy of the villi in
defunctioned intestinal loops. Similarly, it was shown in
several studies that L-glutamine increased adaptation in
intestines that had been damaged by several causes,
preserved the integrity and functionality of the intestines,
improved intestinal immunity and prevented bacterial
translocation (25,29-32). It has been reported that Lglutamine has direct trophic effects on the intestinal
mucosa (33), it prevents adherence of bacteria over
intestinal walls by increasing secretory IgA secretion (34),
it changes the intestinal flora (35), it prevents damage of
free oxygen radicals to the mucosa (36) and it induces
anabolism by increasing cell hydration in the tissue (37).
In our study also, the prognostic parameters in the Lglutamine group were found to be better than those in
the control and insulin groups, and no necrosis was
observed in any of the subjects in the L-glutamine group.
It has been reported that intestinal flora is the source
of septic complications, and it has been suggested that
elimination of intestinal stasis and reduction of the
bacterial count will reduce septic complications in acute
pancreatitis (9,10,13). The development of septic
complications intensifies acute pancreatitis and

deteriorates the prognosis (9,12). Sahin et al. (13)
showed that laxatives reduced the colonic bacterial
population and prevented bacterial translocation in acute
pancreatitis. Similar results were obtained in several
other studies (10,11,38). We also found in our study that
prognostic parameters in the laxative group were better
than in the control and insulin groups. Histopathological
findings were also better in line with prognostic
parameters, and pancreatic necrosis was observed in only
one subject.
It has been reported that insulin may be employed by
nasal, mucosal and oral ways in the treatment of several
auto-immune diseases and type 1 diabetes (39-43).
Several studies report that insulin used orally regulates T
cell proliferation and cytokin secretion, and that it
protects beta cells in the pancreas (42-45). Insulin-like
growth factors (IGF-I and II) secreted from the salivary
glands enhance adaptation in the damaged intestines and
improve intestinal functions (46,47). Based on these
findings, we investigated how oral insulin influenced the
severity of acute pancreatitis. However, all the
parameters in the subjects in the insulin group were
unfavorable, as in the control group, and not a single
positive effect was observed in this group. We think that
the peptide structure of insulin, which may be digested in
the stomach, may be responsible for this result. Favorable
results may be obtained if insulin is allowed to reach the
duodenum and the small intestine by being protected
against gastric acid.
In conclusion, enteral nutrition with L-glutamine dose
not worsen the severity of acute pancreatitis as generally
believed; on the contrary, it enables the disease to be
managed in a less severe course. Laxatives also reduce the
severity of acute pancreatitis, though not to the same
degree. Oral insulin had no effect on the course of acute
pancreatitis in our experimental model. Based on these
findings, oral administration of L-glutamine containing
solutions will both meet the energy demand of the patient
and diminish septic complications in acute pancreatitis.
Correspondence author:
Fatih Mehmet AVfiAR
Meflrutiyet Cad. 28/6
06640 Kocatepe / Ankara - Turkey
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